[The docetaxel radiosensitization experience for the treatment of unresectable esophageal cancer].

@article{Maruyama2005TheDR,
  title={[The docetaxel radiosensitization experience for the treatment of unresectable esophageal cancer].},
  author={Shoji Maruyama and Michio Maruyama and Hideaki Tanami and Masakazu Ebuchi and Itaru Takashima and Kumi Hasegawa and Ayaki Koide and Nobuko Tamura and Yutaka Miyawaki and Masahide Ohbu and Takeshi Nagahama},
  journal={Gan to kagaku ryoho. Cancer & chemotherapy},
  year={2005},
  volume={32 11},
  pages={1724-6}
}
BACKGROUND Docetaxel is an increasingly important drug for the treatment of esophageal cancer. The docetaxel radiosensitization has been established in cancer cell lines. The therapeutic response and toxicity of a weekly docetaxel in combination with radiotherapy for unresectable esophageal cancer were examined. METHODS Ten patients with locally advanced or metastatic squamous cell esophageal cancer were recruited in the following protocol. The median age was 65.7 years. Patients received… CONTINUE READING